UNSPSC 51422323: Betamethasone acibutate

This classification denotes a therapeutic glucocorticoid with the molecular formula C28H37FO7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 90I96070LY, chemically known as 9-fluoro-11beta,17,21-trihydroxy-16beta-methylpregnpa-1,4-diene-3,20-dione 21-acetate 17-isobutyrate but more generally known as betamethasone acibutate, which bears US NIH Compound Identifier 111080.

UNSPSC 51422323 Betamethasone acibutate is a Commodity code for a topical corticosteroid pharmaceutical product, but the recent state and local procurement record shows no relevant activity under this code. The single opportunity tagged to 51422323 is Seminole County, Florida's IFB 60459723LAS for Naloxone and Safe Drug Deactivation Systems — a harm-reduction and emergency-response procurement entirely outside the scope of betamethasone acibutate, a dermatological steroid used to treat inflammatory skin conditions. The mismatch suggests either a coding error in the source record or a county tagging practice that does not align with UNSPSC taxonomy. State and local buyers soliciting actual betamethasone acibutate supplies — whether for county health departments, school district clinics, or municipal emergency medical services — do not appear in the recent opportunities block.

Without documented recent activity aligned to the code's intended scope, no pattern of issuing bodies, geographic concentration, or purchasing volume emerges. Buyers pursuing contracts under UNSPSC 51422323 should verify directly with state purchasing offices, regional cooperative purchasing groups, and individual health departments whether betamethasone acibutate appears in their active RFQ or standing-order frameworks, as the code currently shows no clear demand signal in posted state and local solicitations.